نتایج جستجو برای: admat aysmetric dimethylarginine

تعداد نتایج: 1925  

Journal: :Molecules 2016
Rhys B Murphy Sara Tommasi Benjamin C Lewis Arduino A Mangoni

Dimethylarginine dimethylaminohydrolase (DDAH) is a highly conserved hydrolytic enzyme found in numerous species, including bacteria, rodents, and humans. In humans, the DDAH-1 isoform is known to metabolize endogenous asymmetric dimethylarginine (ADMA) and monomethyl arginine (l-NMMA), with ADMA proposed to be a putative marker of cardiovascular disease. Current literature reports identify the...

Journal: :Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2015
Lidia Hyla-Klekot Piotr Bryniarski Barbara Pulcer Katarzyna Ziora Andrzej Paradysz

BACKGROUND Nephrotic syndrome in children is commonly associated with dyslipidemia, which is considered a risk factor for endothelial dysfunction and atherosclerosis. Recently new markers of endothelial dysfunction, such as asymmetric dimethylarginine (ADMA), have gained importance. Another L-arginine derivative--symmetric dimethylarginine (SDMA)--may reflect the glomerular filtration rate (GFR...

2013
Jana Štikarová Jiří Suttnar Kristýna Pimková Leona Chrastinová-Mášová Jaroslav Čermák Jan E Dyr

Myelodysplastic syndromes (MDS) are hematological malignancies of unclear etiology where oxidative stress may contribute to the pathogenesis. Methylarginines, naturally occurring inhibitors of NO synthase, can increase superoxide generation from uncoupled NO synthase. We found significant increase in concentrations of asymmetric dimethylarginine (0.84 ± 0.32 μmol/L, p = 0.0022) and malondialdeh...

2014
Jiunn-Ming Sheen Yu-Chieh Chen You-Lin Tain Li-Tung Huang

Bile duct ligation (BDL)-treated rats exhibit cholestasis, increased systemic oxidative stress, and liver fibrosis, which ultimately lead to liver cirrhosis. Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of nitric oxide synthase that can decrease the synthesis of nitric oxide. BDL rats have higher plasma and hepatic ADMA levels, which may be due to increased hepatic protein argi...

Journal: :Journal of the American Society of Nephrology : JASN 2009
Takafumi Toyohara Takehiro Suzuki Ryo Morimoto Yasutoshi Akiyama Tomokazu Souma Hiromi O Shiwaku Yoichi Takeuchi Eikan Mishima Michiaki Abe Masayuki Tanemoto Satohiro Masuda Hiroaki Kawano Koji Maemura Masaaki Nakayama Hiroshi Sato Tsuyoshi Mikkaichi Hiroaki Yamaguchi Shigefumi Fukui Yoshihiro Fukumoto Hiroaki Shimokawa Ken-ichi Inui Tetsuya Terasaki Junichi Goto Sadayoshi Ito Takanori Hishinuma Isabelle Rubera Michel Tauc Yoshiaki Fujii-Kuriyama Hikaru Yabuuchi Yoshinori Moriyama Tomoyoshi Soga Takaaki Abe

Hypertension in patients with chronic kidney disease (CKD) strongly associates with cardiovascular events. Among patients with CKD, reducing the accumulation of uremic toxins may protect against the development of hypertension and progression of renal damage, but there are no established therapies to accomplish this. Here, overexpression of human kidney-specific organic anion transporter SLCO4C...

Journal: :Biochemical and biophysical research communications 2010
Rebecca S Lipson Kristofor J Webb Steven G Clarke

Rps2/rpS2 is a well conserved protein of the eukaryotic ribosomal small subunit. Rps2 has previously been shown to contain asymmetric dimethylarginine residues, the addition of which is catalyzed by zinc-finger-containing arginine methyltransferase 3 (Rmt3) in the fission yeast Schizosaccharomyces pombe and protein arginine methyltransferase 3 (PRMT3) in mammalian cells. Here, we demonstrate th...

Journal: :Circulation 2004
John P Cooke

The traditional risk factors of hypercholesterolemia, hypertension, diabetes mellitus, and tobacco exposure identify a subset of patients at greater cardiovascular risk. A variety of clinical phenotypes, biochemical markers, and genetic polymorphisms have been proposed to explain the variance in risk not explained by the traditional factors. Notably, all of the traditional risk factors, as well...

Journal: :Bioorganic & medicinal chemistry letters 2007
Basil Hartzoulakis Sharon Rossiter Herpreet Gill Bernard O'Hara Emily Steinke Paul J Gane Ramon Hurtado-Guerrero James M Leiper Patrick Vallance Judith Murray Rust David L Selwood

An efficient process for the discovery of inhibitors of DDAH enzymes, without the requirement for high throughput screening, is described. Physicochemical filtering of a 308,000-compound library according to drug likeness followed by reciprocal nearest neighbour selection produced a representative subset of 35,000 compounds. Virtual screening on a dual processor PC using FlexX, followed by biol...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید